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DEVELOPMENT AND EVALUATION OF A DNA VACCINE ENCODING 
31-kDa OUTER MEMBRANE PROTEIN OF BRUCELLA MELITENSIS  
 
 
By 
SEYED PARHAM ASHRAFZADEH 
 September 2009 
Chairman:     MD SABRI MOHD YUSOFF, PhD 
Faculty:          Veterinary medicine 
 
Brucellosis is a widespread disease affecting livestock and humans caused by 
Brucella spp., which are facultative, Gram negative intracellular pathogens. In 
Malaysia brucellosis is prevalent especially in animals, which can cause abortion 
and consequent economic losses. The live attenuated strains like Brucella melitensis 
Rev1 and B. abortus S19 and RB51 are being used to control brucellosis in 
domesticated animals however they have some disadvantages, such as these strains 
provoke antibodies to their lipopolysaccharide (LPS), making it difficult to 
distinguish vaccinated animals from those naturally infected. The DNA vaccines 
offer a new approach because they can stimulate both cellular and humoral 
immunities. On the other hand, DNA vaccines have many advantages over 
traditional protein-based vaccines, such as ease of development, inducing a long 
lived immunity, and minimal preparation costs. On account of the fact that, 
vaccination is the only way to control and eradicate the disease, the vaccine which 
can induce antibody in animals and protect them from infection and can overcome 
the drawbacks of current live attenuated vaccines, is essential. 
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In this study, the outer membrane proteins (Omps) of Brucella melitensis 152, 183 
and 293 of local isolates were extracted and characterized using Sodium Dodecyl 
Sulfate-polyacrylamide Gel Electrophoresis (SDS-PAGE). Accordingly, all the 
strains showed major bands were approximately 22, 23, 31, 43 and 94 kDa and 
minor bands were approximately 10, 16, 19, 73 kDa. Immunoblotting was 
conducted using antisera against the whole cells of B. melitensis 183 revealed the 
antigenicity of Omps of the three isolates. Omp31 was one of the antigenic proteins, 
chosen as a candidate for this research. 
 
Omp31 gene from all isolates was amplified, cloned in pcDNA3.1 (+) and 
sequenced. All isolates produced a single DNA fragment approximately at 723 bp. 
The sequence of all isolates was compared with the published sequences to show the 
percentage of the similarity to them which displayed 100% similarity of strain 183, 
99.8% of strain 152, and 99.8% of strain 293 to strain 16M as the reference strain.  
 
To study the immunization of Omp31, DNA vaccination method applied as a novel 
approach for vaccination in BALB/c mice. The mice were divided into four groups: 
vector with insert (pcDNA3.1-Omp31), vector alone (pcDNA3.1), PBS and 
unvaccinated group. In conclusion, Immunization with pcDNA3.1-Omp31 elicited 
antibody response which was detectable 30 days after the first immunization. 
However, No antibody response was detected against other control groups. 
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Oleh 
SEYED PARHAM ASHRAFZADEH 
September 2009 
Pengerusi: MD. SABRI MOHD YUSOFF, PhD 
Fakulti: Perubatan Veterinar 
 
Brucellosis ialah penyakit yang merebak ke atas haiwan ternakan dan manusia yang 
disebabkan oleh bakteria Brucella spp., di mana ianya fakultatif, patogen di dalam 
sel dan bersifat Gram negatif. Di Malaysia, brucellosis lazimnya menjangkiti 
haiwan sehingga menyebabkan keguguran dan kerugian ekonomi yang besar. 
Bakteria hidup yang dilemahkan  seperti Brucella melitensis Rev1 dan B. abortus 
S19 dan RB51 digunakan sebagai kawalan brucellosis ke atas haiwan ternakan 
tempatan. Walaupun terdapat beberapa kelemahan seperti strain merangsang 
antibodi kepada lipopolisakarida (LPS), ianya menyebabkan sukar dibezakan di 
antara haiwan yang divaksin dan haiwan yang dijangkiti secara semulajadi. Vaksin 
DNA dapat menawarkan dengan pendekatan di mana ianya dapat merangsang 
imuniti ketisuan dan humoral. Dengan kata lain, vaksin DNA mempunyai kelebihan 
daripada vaksin tradisional berdasarkan protin seperti senang dibangunkan, 
menginduksikan imuniti berpanjangan, dan kos penyediaan yang rendah. Secara 
faktanya, pemvaksinan merupakan cara untuk mengawal dan menghapuskan 
penyakit ini, di mana pemvaksinan menginduksikan antibodi.  
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Di dalam kajian ini, protin selaput luar (Omp) dari Brucella melitensis 152, 183 dan 
293 tempatan diekstrak dan diasingkan meggunakan “Sodium Dodecyl Sulfate-
Polyacrylamide Gel Electrophoresis” (SDS-PAGE). Semua strain menunjukkan 
perbezaan jalur yang kecil dan besar. “Immunoblotting” yang dijalankan 
menggunakan antiserum terhadap seluruh sel B. melitensis 183 menunjukkan 
antigenik protin selaput luar (Omp) ke atas tiga isolat ini. Protin selaput luar 31 
(Omp31) merupakan salah satu daripada antigenik protin yang dipilih di dalam 
kajian ini. 
 
Gen protein selaput luar (Omp31) dari semua isolat dilipatgandakan, diklon di 
dalam vektor pcDNA3.1 (+) dan dijujukkan untuk mempastikan semua susunan 
berada di dalam bingkainya. Kesemua isolat menghasilkan satu produk, iaitu kira-
kira 723 bp. Jujukan kesemua isolat kemudiannya dibandingkan dengan jujukan 
terbitan untuk menunjukkan peratus persamaan di mana menunjukkan persamaan 
100% dengan strain 183, 99.8% dengan strain 152, dan 99.8% dengan strain 293 
apabila dibandingkan dengan strain rujukan 16M. 
 
Di dalam kajian terhadap immunisasi protein selaput luar 31 (Omp31), kaedah 
pemvaksinan DNA digunapakai terhadap pemvaksinan di dalam tikus BALB/c. 
Tikus dibahagikan kepada 4 kumpulan: vektor dengan kemasukan pcDNA3.1-
Omp31, vektor sahaja (pcDNA3.1), PBS  dan kumpulan yang tidak divaksin. 
Immunisasi dengan pcDNA3.1-Omp31 menunjukkan respon antibodi di mana ianya 
dapat dikesan pada hari ke 30 selepas immunisasi pertama. Walaubagaimanapun, 
tiada pengesanan antibodi dapat dilihat pada kumpulan-kumpulan yang lain.  
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CHAPTER 1 
 
INTRODUCTION 
 
Brucellosis is a zoonotic disease that can happen in both humans and animals. In 
animals, the most vivid sign of disease is abortion. Transmission happens when 
animals are exposed to contaminated food or water or lick a newly aborted fetus 
(Corbel, 1997). Humans can also contract infection by ingesting contaminated 
milk or other dairy products (Fraser, 1986). 
 
Brucellosis is still endemic in many developing countries causing important 
economic losses. In Malaysia, the presence of brucellosis in large ruminants was 
confirmed by the isolation of Brucella abortus in 1950 and Brucella suis in 1963. 
The National Program for ‘The Area-Wise Eradication of Bovine Brucellosis 
which started working in 1979 had reduced the prevalence of bovine brucellosis 
in Malaysia from 3.3% in 1979 to 0.23 in 1988. It was then envisaged that by 
1995 bovine brucellosis in Malaysia had been eradicated. However, the 
prevalence of brucellosis was reported to be relatively high (<2%) again (Anon, 
2005). 
 
The attenuated strains like Brucella melitensis Rev1 and B. abortus S19 and 
RB51 are applied to control brucellosis in domesticated animals. However, these 
attenuated vaccines are not efficient enough because of their limited efficacy and 
potential to lead to the disease in humans. Moreover, both B. abortus S19 and B. 
melitensis Rev1 strains provoke antibodies to their lipopolysaccharide (LPS), 
making it difficult to distinguish vaccinated animals from those naturally infected 
(Baldi et al., 1996). Recently, Brucella spp., have been reported as a dangerous 
disease by the Centers for Disease Control (Izadjoo et al., 2004). So, a vaccine 
that is protective against Brucella is desirable. Based on the extensive economic 
losses that Brucella infection in animals can induce, eradication of the disease 
worldwide is very crucial. Vaccination is an efficient mean of protecting animals 
that have not already been exposed to the disease (Fraser, 1986). 
 
The DNA vaccines offer a new approach because they can stimulate both cellular 
and humoral immunities. DNA vaccines have many advantages over traditional 
protein-based vaccines, such as ease of development, inducing a long lived 
immunity, and minimal preparation costs (Srivastava and Liu, 2003). Because of 
the effectiveness, previous studies have shown that DNA vaccination with sodC 
(Onate, 2003), lumazine synthase gene (Velikovsky et al., 2002), and P39 (Al-
Mariri et al., 2001) can induce good antibody levels in animals. Cassataro et al. 
(2005b) showed that Omp31 of B. melitensis can confer partial protection against 
B. melitensis and B. ovis protection, which maybe because of not sufficient 
antibody production or improper expression vector. Accordingly, using Omp31 
with another vector is necessary to evaluate a DNA vaccine using Omp31 of B. 
melitensis. In contrast to live attenuated vaccines, there are no concerns of 
contracting disease, and DNA vaccines are stable. Identification of Brucella spp. 
antigens with the ability to elicit a protective immune response is of great interest 
for the development of vaccines. As shown in mouse model, active immunization 
1.2 
 
with Brucella spp. smooth LPS (Pugh, 1991), or O-polysaccharide chain 
(Jacques, 1991) and passive protection experiments with anti-polysaccharide 
monoclonal antibodies (mAbs) (Vizcaino and Fernandez-Lago, 1994) smooth 
LPS plays an important role in protective immunity. mAbs rose against several 
Brucella outer membrane proteins (Omps) gave slight protection in mice against 
infection caused by smooth Brucella strains (Cloeckaert et al., 1991; Jacques et 
al., 1992). However, a mixture of anti-Omp mAbs has been proved to protect 
against rough Brucella ovis infection (Bowden et al., 1995) and it has also been 
suggested that the Omps are important in the development of protective cellular 
immunity, while the transfer of immune T cells protects against Brucella 
infection (Plommet et al., 1985). Cloning of the Brucella Omps is an attractive 
approach for the determination of their potential goodness for vaccination 
purposes.  
 
With regard to the potential of Omps as a vaccine candidate, the objectives of this 
study were: 
1. to determine the Omps profiles of Brucella melitensis 152, 183, and 293 
using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). 
2. to determine the antigenicity of the Omps of Brucella melitensis 152, 183, 
and 293 using Western blotting against homologous and heterologous 
antisera.  
3. to amplify, clone and sequence Omp31 as one of the most antigenic 
protein gene of Brucella melitensis 152, 183, and 293. 
1.3 
 
1.4 
 
4. to evaluate the immunization of the DNA vaccine encoding the antigenic 
protein in mice. 
 
2.1 
 
 
 
CHAPTER 2 
 
            LITERATURE REVIEW 
 
2.1    Brucellosis 
 
Brucellosis is a widespread, zoonotic and infectious disease of animals and humans 
caused by groups of Brucella genus that is economically important (Alton, 1990). 
Since the microorganism is transmitted between animals within herd, it is capable of 
causing abortions during breeding seasons (Wilesmith, 1978). It can be transmitted 
from animals like cats, sheep, goats, bison and buffalo through direct contact with 
blood placenta, fetuses, uterine secretions or by consumption of infected and raw 
animal products especially milk and milk products. Brucellosis in sheep and goats is 
mainly caused by Brucella melitensis (Hamdy, 1992). In Malaysia, the presence of 
brucellosis in large ruminants was confirmed by the isolation of Brucella abortus in 
1950 and Brucella suis in 1963. The National Program for ‘The Area-Wise 
Eradication of Bovine Brucellosis which started working in 1979 had reduced the 
prevalence of bovine brucellosis in Malaysia from 3.3% in 1979 to 0.23 in 1988. It 
was then envisaged that by 1995 bovine brucellosis in Malaysia had been 
eradicated. However, the prevalence of brucellosis was reported to be relatively high 
(<2%) again (Anon, 2005). 
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The frequency of transmission of B. melitensis is low, but the existence of latent 
infections greatly increases the difficulty of eradicating the disease. This happens as 
B. melitensis persists without having a detectable immune response because of 
immunotolerance and pathogenicity way. 
 
The intracellular localization of these bacteria shows that the immunity towards 
Brucella requires a cell-mediated immune response, which makes the Th1 arm of 
the immune response very important for controlling the infection (Splitter et al., 
1996).The protection against this infection needs a long-lived cellular immune 
response, depending on the processing of the bacteria by macrophages (Araya et al., 
1989; Baldwin and Winter, 1994).  
 
2.2    Brucella species 
 
Bacteria of the genus Brucella are small, facultative intracellular, Gram-negative, 
non-motile and non-spore forming coccobacilli bacterial pathogens that infect both 
phagocytic and non-phagocytic cells (Alton 1990; Smith and Fitch, 1990). At the 
moment, there are six recognized species regarding the host specificity: B. abortus 
in cattle, B. canis in dogs, B. melitensis in goats, B. neotamea in desert wood rats, B. 
ovis in sheep and B. suis in pigs, reindeer and hares (Morgan and Corbel, 1976). 
Recently a large number of Brucella strains have been isolated from marine 
mammals and has proposed to be included in two new species, B. cataceae and B. 
pinnipediae (Cloeckaert et al., 2001). B. melitensis is the most pathogenic species 
for humans and the lowest species specific, infecting goats, sheep, cows, camels, 
and dogs (Young, 1995). 
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Malta fever which is also known as Mediterranean, Gibraltar, or undulant fever and 
porcine brucellosis caused by B. melitensis and B. suis infection of humans, 
respectively, are more apparent clinically than Bang’s disease (B.abortus infection), 
whereas among the available species only  B. canis causes anecdotal mild infections 
in humans (Corbel, 1997) . 
 
Brucellae are classified in a tight phylogenetic family, the family Rhizobiaceae of 
the alpha-2 subgroup of the class Proteobacteria, including Orchrobactrum, 
Bartonella, Rhizobium and Agrobacterium (Velasco et al,. 1998). At the DNA level, 
the different species have more than 90% homology in DNA-DNA hybridization 
assays. The high similarity of Brucellae according to DNA-DNA hybridization 
suggested that they may represent a monospecies genus (Verger et al., 1985). 
 
2.3    Ultrastructure of Gram-negative Bacteria 
 
Gram-negative bacteria have three structural regions, consisting of appendages in 
the shape of flagella and pili (or fimbriae), cell wall and cytoplasmic region. The 
cell wall is approximately 10nm in diameter and composing of a single layer of 
peptidoglycans surrounded by membranous structure called the outer membrane. 
The outer membrane has unique components like lipopolysaccharides as endotoxin, 
outer membrane protein, lipoprotein and phospholipid. The cytoplasm surrounded 
the cell genome which named DNA, contains ribosomes and variable other 
inclusions. Fimbria is used mostly to describe the conjugative filaments of many 
Gram-negative bacteria. They are shorter and straighter than flagella and appear 
anchored through the outer membrane (Jawetz et al, 2004) (Figure 2.1). 
